Literature DB >> 23327801

The role of the IL-23/IL-17 axis in the pathogenesis of Graves' disease.

Li Zheng1, Peng Ye, Chun Liu.   

Abstract

This study is to explore the role of IL-23/IL-17 axis in subjects with Graves' disease, while IL-23/IL-17 axis plays an important role in a number of autoimmune diseases, but it's not clear in Graves' disease. Thirty-three patients with Graves' disease as a GD group, 15 patients with euthyroid GD as eGD group and 22 healthy volunteers as a control group whose age- and sex-matched. Peripheral blood was collected and peripheral blood mononuclear cells (PBMCs) were isolated in the both groups, then PBMCs were cultured in the presence or absence of IL-23 in vitro. The expression of retinoid-related orphan receptor gamma t (RORγt) and IL-17 mRNA were examined by Semi-quantitative RT-PCR, and the levels of IL-17 protein were measured by enzyme-linked immunosorbent assay. The expression of RORγt, IL-17 mRNA and IL-17 protein levels were markedly higher in GD and euthyroid GD group as compared with the control group. IL-17 levels were still higher in euthyroid GD patients. When PBMCs derived from the three groups were cultured in vitro with or without IL-23, the expression of RORγt in GD group with IL-23 dramatically increased as compared with that in GD group without IL-23 and in control group with IL-23. RORγt expression of PBMCs from eGD group cultured with IL-23 was increased compared with that cultured without IL-23. The levels of IL-17 mRNA and the protein were also significantly higher than that of GD and eGD cultured without IL-23 and control group. There was no difference of the expression of RORγt mRNA and IL-17 protein levels between GD and eGD group cultured with or without IL-23. Our studies demonstrated that IL-23/IL-17 axis is associated with the pathogenesis of Graves' disease in it activated term. This effect is not dependent on thyroid function, but may be associated to the immunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23327801     DOI: 10.1507/endocrj.ej12-0264

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

Review 1.  Rituximab in the Treatment of Thyroid Eye Disease: A Review.

Authors:  Rochella A Ostrowski; Melissa R Bussey; Yasmin Shayesteh; Walter M Jay
Journal:  Neuroophthalmology       Date:  2015-06-17

Review 2.  T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity.

Authors:  Roberto González-Amaro; Mónica Marazuela
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

3.  Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside.

Authors:  Fatemeh Rajaii; Allison N McCoy; Terry J Smith
Journal:  Expert Rev Ophthalmol       Date:  2014-06

4.  Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves' disease model.

Authors:  Q Yuan; Y Zhao; X Zhu; X Liu
Journal:  J Endocrinol Invest       Date:  2016-11-07       Impact factor: 4.256

Review 5.  The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases.

Authors:  Jacek Tabarkiewicz; Katarzyna Pogoda; Agnieszka Karczmarczyk; Piotr Pozarowski; Krzysztof Giannopoulos
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-06-11       Impact factor: 4.291

6.  Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms.

Authors:  Seyed Ali Ghaffari; Maryam Nemati; Hossain Hajghani; Hossainali Ebrahimi; Abdolkarim Sheikhi; Abdollah Jafarzadeh
Journal:  Iran J Neurol       Date:  2017-01-05

7.  Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases.

Authors:  Marta Rydzewska; Michał Jaromin; Izabela Elżbieta Pasierowska; Karlina Stożek; Artur Bossowski
Journal:  Thyroid Res       Date:  2018-02-13

8.  Identification of Novel Molecular Markers of Human Th17 Cells.

Authors:  Anna Sałkowska; Kaja Karaś; Iwona Karwaciak; Aurelia Walczak-Drzewiecka; Mariusz Krawczyk; Marta Sobalska-Kwapis; Jarosław Dastych; Marcin Ratajewski
Journal:  Cells       Date:  2020-07-03       Impact factor: 6.600

9.  Functional Analysis of the rs774872314, rs116171003, rs200231898 and rs201107751 Polymorphisms in the Human RORγT Gene Promoter Region.

Authors:  Marcin Ratajewski; Marcin Słomka; Kaja Karaś; Marta Sobalska-Kwapis; Małgorzata Korycka-Machała; Anna Sałkowska; Jarosław Dziadek; Dominik Strapagiel; Jarosław Dastych
Journal:  Genes (Basel)       Date:  2017-04-21       Impact factor: 4.096

10.  Elevated Serum IL-17 Expression at Cessation Associated with Graves' Disease Relapse.

Authors:  Jianhui Li; Xiaohua Sun; Danzhen Yao; Jinying Xia
Journal:  Int J Endocrinol       Date:  2018-03-11       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.